Oncychomycosis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies | Blueberry Therapeutics, AmtixBio, Mycovia Pharmaceuticals, Polichem, Onicor, Nihon Nohyaku

DelveInsight's, "Onychomycosis Pipeline Insight 2025" report provides comprehensive insights about 11+ companies and 11+ pipeline drugs in Onychomycosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our comprehensive Oncychomycosis Pipeline Report to stay informed about the latest advancements. Download copy now @ Oncychomycosis Pipeline Outlook- https://www.delveinsight.com/sample-request/onychomycosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Oncychomycosis Pipeline Report
• DelveInsight's Oncychomycosis pipeline report depicts a robust space with 11+ active players working to develop 11+ pipeline therapies for Oncychomycosis treatment.
• The leading Oncychomycosis Companies such as Blueberry Therapeutics, AmtixBio, Mycovia Pharmaceuticals, Polichem, Onicor, Nihon Nohyaku, and others.
• Promising Oncychomycosis Pipeline Therapies such as BB2603, ATB-1651 and others.

Discover how the Oncychomycosis treatment paradigm is evolving. Access DelveInsight's in-depth Oncychomycosis Pipeline Analysis for a closer look at promising breakthroughs @ Oncychomycosis Clinical Trials and Studies- https://www.delveinsight.com/sample-request/onychomycosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Oncychomycosis Emerging Drugs Profile

• BB2603: Blueberry Therapeutics
Blueberry is developing a new topical antifungal spray formulation of terbinafine (BB2603 om) for the treatment of onychomycosis using our nanodelivery platform technology. The aim is to apply the spray directly to the nail, and through enhanced delivery of the active substance through the nail, to match the cure rates of the more effective oral formulations in a topical medicine, without the associated safety concerns. The drug is currently being evaluated under Phase II clinical trial for the treatment of patients with Onychomycosis.

• ATB-1651: AmtixBio
ATB-1651 is a potential first-in-class drug candidate targeting fungal cell wall components. It is a new drug candidate that acts quickly on virulent fungi, can reliably kill fungi, and reliably suppresses the creation of resistant bacteria. The drug is currently being evaluated under Phase II clinical trial for the treatment of patients with Onychomycosis.

The Oncychomycosis Pipeline Report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Oncychomycosis with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Oncychomycosis Treatment.
• Oncychomycosis Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Oncychomycosis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Oncychomycosis market.

Get a detailed analysis of the latest innovations in the Oncychomycosis pipeline. Explore DelveInsight's expert-driven report today! @ Oncychomycosis Unmet Needs- https://www.delveinsight.com/sample-request/onychomycosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Oncychomycosis Companies
Blueberry Therapeutics, AmtixBio, Mycovia Pharmaceuticals, Polichem, Onicor, Nihon Nohyaku, and others.

Onychomycosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intravenous
• Subcutaneous
• Oral
• Intramuscular

Oncychomycosis Products have been categorized under various Molecule types such as
• Monoclonal antibody
• Small molecule
• Peptide

Download DelveInsight's latest report to gain strategic insights into upcoming Oncychomycosis Therapies and key Oncychomycosis Developments @ Oncychomycosis Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/onychomycosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Oncychomycosis Pipeline Report
• Coverage- Global
• Oncychomycosis Companies- Blueberry Therapeutics, AmtixBio, Mycovia Pharmaceuticals, Polichem, Onicor, Nihon Nohyaku, and others.
• Oncychomycosis Pipeline Therapies- BB2603, ATB-1651 and others.
• Oncychomycosis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Oncychomycosis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Which companies are leading the race in Oncychomycosis drug development? Find out in DelveInsight's exclusive Oncychomycosis Pipeline Report-access it now! @ Oncychomycosis Emerging Drugs and Major Companies- https://www.delveinsight.com/sample-request/onychomycosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Onychomycosis: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Onychomycosis- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Drug name: Company name
9. Drug profiles in the detailed report.....
10. Mid Stage Products (Phase II)
11. BB2603: Blueberry Therapeutics
12. Drug profiles in the detailed report.....
13. Early Stage Products (Phase I)
14. ATB-1651: AmtixBio
15. Drug profiles in the detailed report.....
16. Preclinical and Discovery Stage Products
17. Drug Name: Company Name
18. Drug profiles in the detailed report.....
19. Inactive Products
20. Onychomycosis Key Companies
21. Onychomycosis Key Products
22. Onychomycosis- Unmet Needs
23. Onychomycosis- Market Drivers and Barriers
24. Onychomycosis- Future Perspectives and Conclusion
25. Onychomycosis Analyst Views
26. Onychomycosis Key Companies
27. Appendix

List of Top Selling Market Research Reports in 2025

Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/report-store/intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.